Search results for "Ventricular hypertrophy"

showing 10 items of 107 documents

Left Ventricular Hypertrophy in the Spanish Hypertensive Population. The ERIC-HTA Study

2006

Introduction and objectives. Left ventricular hypertrophy (LVH) is the earliest manifestation of cardiac damage in hypertension. Its appearance is associated with a poor cardiovascular prognosis. The objectives of this study were to determine the prevalence of electrocardiographic LVH and to assess the epidemiological characteristics of hypertensive patients receiving primary care. Patients and method. A cross-sectional multicenter study of hypertensive patients aged 55 years or more was carried out in a primary care setting. Blood pressure was measured using the standard method. Cardiovascular history was determined from medical records and LVH was assessed electrocardiographically using C…

Malemedicine.medical_specialtyPopulationDiseaseLeft ventricular hypertrophyDiabetes ComplicationsElectrocardiographySex FactorsRisk FactorsInternal medicineDiabetes mellitusEpidemiologymedicineHumanscardiovascular diseaseseducationAgededucation.field_of_studyChi-Square DistributionPrimary Health CareCardiovascular Historybusiness.industryMedical recordSmokingAge FactorsGeneral MedicineMiddle Agedmedicine.diseaseCross-Sectional StudiesBlood pressureCardiovascular DiseasesSpainData Interpretation StatisticalHypertensionCardiologyFemaleHypertrophy Left VentricularKidney DiseasesbusinessRevista Española de Cardiología (English Edition)
researchProduct

Impact of metabolic syndrome on left ventricular mass: Is the same in all ethnic groups and in men and women?

2007

[1] Mule G, Nardi E, Cottone S, et al. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Int J Cardiol 2007;121:267–75. [2] Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8. [3] IsomaaB,Almgren P, TuomiT, et al. Cardiovascularmorbidity andmortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9. [4] Reilly MP, Rader DJ. The metabolic syndrome:…

Malemedicine.medical_specialtyRaceEthnic groupSindrome metabolica Ipertrofia ventricolare sinistra Ipertensione essenziale.OverweightLeft ventricular hypertrophyEssential hypertensionLeft ventricular massLeft ventricular massRace (biology)Sex FactorsDiabetes mellitusInternal medicineHumansMedicineCardiac structureObesityInternational diabetes federationbusiness.industryRacial GroupsGenderOverweightmedicine.diseaseMetabolic syndromeHypertensionCardiologyFemaleHypertrophy Left Ventricularmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk

2015

OBJECTIVE This study was designed to evaluate the relationship among circulating adiponectin (ADPN), left ventricular mass (LVM) and cardiometabolic comorbidities in subjects at higher global cardiovascular risk (score of “ Cuore Project “) METHODS. 115 consecutive subjects were grouped according to normal or low ADPN levels. Left ventricular internal diameter (LVID/h), total LV mass (LVM), LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters, by pulsed-wave Doppler were calculated. RESULTS Low-ADPN subjects were characterized by a significant higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, dia…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiac VolumeHeart VentriclesCardiac VolumeLeft ventricular hypertrophyRisk AssessmentVentricular Function LeftLeft ventricular massRisk FactorsInternal medicinePrevalencemedicineHumansEchocardiography Doppler PulsedVentricular functionAdiponectinbusiness.industryStroke VolumeAdiponectinGlobal cardiovascular riskleft ventricular hypertrophyGeneral MedicineStroke volumeMiddle AgedPrognosismedicine.diseaseItalyCardiovascular DiseasesCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessBiomarkersActa Cardiologica
researchProduct

Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy

2014

This study was designed to evaluate the prevalence of cardiometabolic comorbidities and the changes in left ventricular geometry and function in 135 subjects subgrouped according to low or normal total adiponectin plasma (ADPN) levels. Left ventricular (LV) internal diameter/height, total LV mass (LVM) and LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters by pulsed-wave Doppler were calculated. Body mass index (BMI) (p < 0.0001), waist-to-hip ratio (p < 0.03), triglycerides (p < 0,001), prevalence of obesity (p < 0.005), visceral obesity (p < 0.003), left ventricular hypertrophy (LVH) (p < 0.001), metabolic syndrome (p < 0.000…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaDiastoleBlood PressureComorbidityLeft ventricular hypertrophyBody Mass IndexCoronary artery diseaseMetabolic DiseasesInternal medicineInternal MedicinemedicineHumansObesityAgedAged 80 and overEjection fractionAdiponectinbusiness.industrymedicine.diseaseAdiponectin Cardiometabolic comorbidities Left ventricular hypertrophyBlood pressureCardiovascular DiseasesEmergency MedicineCardiologyFemaleHypertrophy Left VentricularAdiponectinMetabolic syndromebusinessBody mass indexMetabolism Inborn Errors
researchProduct

Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities.

2019

BACKGROUND: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients. MATERIALS AND METHODS: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) b…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesHemodynamics030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineWaist–hip ratioobesity cardiac structureInternal medicinemedicineHumansCardiac structure030212 general & internal medicineObesityPhenomicsskin and connective tissue diseasesCorrelation of DataEchocardiography Doppler PulsedAdiponectinbusiness.industryCardiometabolic Risk FactorsStroke VolumeGeneral MedicineOrgan SizeMiddle Agedmedicine.diseaseObesityBlood pressureItalyEchocardiographycardiovascular systemCardiologyFemaleHypertrophy Left Ventricularsense organsAdiponectinCardiology and Cardiovascular MedicinebusinessFunction (biology)Acta cardiologica
researchProduct

Cardiac arrhythmias as correlated with the circadian rhythm of arterial pressure in hypertensive subjects with and without left ventricular hypertrop…

1990

To evaluate the relationship among supraventricular and ventricular arrhythmias with blood pressure and heart rate (HR) values, we studied 2 groups of 20 hypertensive men with (group I) and without (group II) left ventricular hypertrophy. Ambulatory electrocardiographic tracings were recorded continuously, together with ambulatory arterial pressure. Systolic (SBP) and diastolic (DBP) blood pressure values measured over 24 h showed no difference between the two groups, but we found greater variability in SBP in group I. The incidence of ventricular and supraventricular arrhythmias was significantly higher in patients of group I; moreover, we found a strong correlation between the incidence o…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaSystoleHeart VentriclesDiastoleBlood PressureCardiomegalyLeft ventricular hypertrophyVentricular Function LeftMuscle hypertrophyHeart RateInternal medicineHeart ratemedicineHumansPharmacology (medical)cardiovascular diseasesSystolePharmacologySupraventricular arrhythmiamedicine.diagnostic_testbusiness.industryArrhythmias CardiacGeneral Medicinemedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheCircadian RhythmBlood pressureHypertensioncardiovascular systemCardiologybusinessArrhythmias Cardiac/physiopathology* Blood Pressure/physiology* Cardiomegaly/physiopathology* Circadian Rhythm/physiology* Heart Rate/physiology Heart Ventricles/physiopathology Humans Hypertension/complications Male Systole Ventricular Function Left/physiologyElectrocardiographycirculatory and respiratory physiology
researchProduct

Electrocardiographic Abnormalities and Mortality in Epilepsy Patients

2021

Background and Objectives: People with epilepsy (PWE) have a 2–3 times higher mortality rate than the general population. Sudden unexpected death in epilepsy (SUDEP) comprises a significant proportion of premature deaths, whereas sudden cardiac death (SCD) is among the leading causes of sudden death in the general population. Cardiac pathologies are significantly more prevalent in PWE. Whether electrocardiographic (ECG) parameters are associated with remote death in PWE has yet to be elucidated. The study objective was to assess whether interictal ECG parameters are associated with mortality in the long-term. Materials and Methods: The study involved 471 epilepsy patients who were hospitali…

Medicine (General)medicine.medical_specialtyPopulationQT intervalSudden deathelectrocardiographic parametersArticleSudden cardiac deathShort QTc IntervalElectrocardiographyQRS complexR5-920Heart RateRisk Factorsdeath in epilepsyInternal medicinesudden cardiac death risk markersshort QTmedicineHumanscardiovascular diseasesPR intervaleducationeducation.field_of_studybusiness.industryMortality rateArrhythmias CardiacGeneral Medicinemedicine.diseaseleft ventricular hypertrophyDeath Sudden CardiacCardiologyepilepsybusinessMedicina
researchProduct

Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease.

2007

Aims: Left ventricular hyper- trophy (LVH) is a predictor for cardiovascu- lar mortality, and it is considered to be a surro- gate marker of preclinical cardiovascular dis- ease. This study aimed at evaluating whether fetuin-A plasma levels are decreased in pa- tients with moderate chronic kidney disease (CKD) and their linkage to plasma concentra- tions of hs-C-reactive protein (CRP), cardio- trophyn-1 (CT-1), tumor necrosis factor- (TNF-), propeptide of collagen Type I (PIP) and to LVH. Material and methods: We enrolled 64 moderate CKD and 55 essential hypertensives (EH) with normal renal func- tion as controls. All the patients underwent an echocardiographic examination; plasma sam- ples…

NephrologyAdultMalePhosphopeptidesmedicine.medical_specialtyInflammationEnzyme-Linked Immunosorbent AssayLeft ventricular hypertrophyMuscle hypertrophyinflammation left ventricular hypertrophy chronic kidney diseaseStatistical significanceInternal medicineMedicineHumansMass indexcardiovascular diseasesInflammationAnalysis of Variancebusiness.industryTumor Necrosis Factor-alphaCase-control studyGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyC-Reactive ProteinNephrologyEchocardiographyCase-Control StudiesCardiologyCytokinesKidney Failure ChronicRegression AnalysisFemaleHypertrophy Left Ventricularalpha-Fetoproteinsmedicine.symptombusinessBiomarkersProcollagenKidney diseaseClinical nephrology
researchProduct

Oxidant stress and endothelial activation in hypertensive patients with and without left ventricular hypertrophy

2006

Oxidant stress endothelial activation hypertension left ventricular hypertrophy
researchProduct

0204: Proteome-wide sex-related differences in response to mouse thoracic aortic constriction: molecular bio-signature of failing hearts

2014

Chronic pressure overload (PO) induces pathological left ventricular hypertrophy (LVH) leading to congestive heart failure (HF). Over-expression of FKBP12.6 (FK506 binding protein (K)) in mice should prevent Ca2+-leak during diastole and may improve overall cardiac function. In order to decipher molecular mechanisms involved in thoracic aortic constriction (TAC)-induced cardiac remodelling and the influence of gender and genotype, we performed a proteomic analysis using 2D-DIGE, mass spectrometry and bioinformatics techniques to identify alterations in characteristic biological networks. Wild type (W) and K mice of both genders underwent TAC. Thirty days post-TAC, the altered cardiac remode…

Pressure overloadCardiac function curvemedicine.medical_specialtyHuntingtinFatty acid metabolismbiologybusiness.industryDiastolemedicine.diseaseLeft ventricular hypertrophychemistry.chemical_compoundEndocrinologychemistryHeart failureInternal medicinebiology.proteinmedicineCardiology and Cardiovascular MedicinebusinessCalreticulinArchives of Cardiovascular Diseases Supplements
researchProduct